Nektar Therapeutics
NKTR
#4576
Rank
HK$16.45 B
Marketcap
HK$588.23
Share price
-0.01%
Change (1 day)
454.60%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$62.22

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$62.47. In 2024 the company made an earnings per share (EPS) of -HK$69.44 an increase over its 2023 EPS that were of -HK$171.65.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$62.22-10.4%
2024-HK$69.44-59.54%
2023-HK$171.65-25.89%
2022-HK$231.61-31.12%
2021-HK$336.2514.86%
2020-HK$292.75-1.19%
2019-HK$296.27-163.96%
2018HK$463.22-725.4%
2017-HK$74.07-42.73%
2016-HK$129.3383.33%
2015-HK$70.5439.53%
2014-HK$50.55-69.29%
2013-HK$164.60-6.67%
2012-HK$176.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.66-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.32-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$5.17-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.93-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.22-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland